United Patients Group

FEBRUARY 7, 2023

Medical cannabis is used to treat a variety of conditions, such as HIV/AIDS, cancer, chronic pain and more. Medical cannabis is used to treat a variety of conditions, such as HIV/AIDS, cancer, chronic pain and more. Limonene is a mood-boosting terpene that can help with inflammation and pain relief.

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

Veriheal

JUNE 20, 2022

.” The LPP’s mission is: “Through intervention, advocacy, and awareness campaigns the Last Prisoner Project works to redress the past and continuing harms of these unjust laws and policies.” The FDA has also approved a few cannabis-based pharmaceutical drugs. According to the U.S.

Chronic Pain 97

Chronic Pain Advocacy Pharmaceutical Legalization 97

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). For example, if your insomnia is due to pain or anxiety, cannabis can help you get some restful sleep. antibiotics).

Blood Pressure 106

Blood Pressure Sleep Chronic Pain Digestion 106

Veriheal

JANUARY 12, 2023

The law also permits the agricultural production of cannabis and hemp for industrial purposes, with a heavy emphasis on pharmaceutical crops. . Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023.

Medicine 97

Medicine Chronic Pain Consumption Cannabis 97

Cannabis Law Report

APRIL 1, 2022

CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years. It also owns a majority stake in LVL Health , a chronic pain clinic, alongside a minority stake in cannabinoid-based biopharmaceutical company Kingdom Therapeutics.

Chronic Pain 52

Chronic Pain Pharmaceutical Sativa Business 52

Cannabis Law Report

JUNE 7, 2019

The farm is run by GW Pharmaceuticals, where around two million cannabis plants have been produced since its opening in 1998. Those suffering from epilepsy, nausea and chronic pain due to chemotherapy are now given the option to get the drug on prescription, reports The Mirror . Something has finally happened in Sittingbourne.

Chronic Pain 40

Chronic Pain Epilepsy Legalization Pharmaceutical 40

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. As such, patients report reduced reliance on opioids and other pain medications, which often come with severe side effects.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Cannabis Law Report

JUNE 26, 2019

In May 2019, Florida Commissioner of Agriculture Nikki Fried announced that a newly-created and appointed Medical Marijuana Advisory Committee of 18 doctors, lawyers, patients, industry leaders, and advocates will be implemented in order to “advance and modernize policies” to move Florida into the future of medical marijuana.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Weedistry

DECEMBER 29, 2018

I previously worked as an emergency room doctor and have witnessed firsthand how helpful this drug can be for patients struggling with chronic pain and a myriad of symptoms. Before the amendment was passed, opponents said that approving access to medical marijuana would result in a veritable plague of social ills.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45

Cannabis Law Report

DECEMBER 22, 2019

On April 22, 2019, United Nations-based cannabis correspondent and global drug policy analyst Sara Brittany Somerset took advantage of our collective national climate focus to address the “ cannabis carbon footprint ” issue with her pertinent Earth Day Begs The Question: Is Cannabis Farming Sustainable?

Packaging 74

Packaging Seed-To-Sale Agriculture Cultivation 74

Sensi Seeds

JANUARY 4, 2019

It should be noted that the CMA represents Canadian physicians, promoting, among other things, health policies, strategies, and access to quality health care. The Canadian Medical Association (CMA) was clearly against having its members prescribe cannabis to patients.

Medicine 75

Medicine Research and Development Patients Programs 75

The Cannigma

AUGUST 29, 2021

The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”. Across the United States, the most common health condition treated with medical cannabis is chronic pain.

Blood Pressure 106

Blood Pressure Marijuana Conditions Sleep 106

SpeedWeed

APRIL 30, 2021

“With about 30 days left in the legislative session, we are so pleased to see the Texas House advancing meaningful changes to our state’s marijuana laws,” said Heather Fazio, director of Texans for Responsible Marijuana Policy, to Marijuana Moment. Now the focus shifts to the Senate, which has historically been a steep uphill battle.”.

Chronic Pain 52

Chronic Pain Concentrates Conditions Therapy 52

SpeedWeed

MAY 17, 2021

Doctors initially prescribed highly addictive opioids like OxyContin and Tramadol to treat his injuries, but the firefighter didn’t like being under the influence of these pharmaceuticals. Like many other people suffering from chronic pain, Martin was eventually able to replace his opioid use with medical marijuana.

Legalization 52

Legalization Chronic Pain Collective State Laws 52

CannaTech

MARCH 29, 2019

While the amendments to the scheduling of marijuana for medical use were intended to increase access, in reality, only patients suffering from epilepsy, MS, side effects of chemotherapy and chronic pain are eligible. This neglects many other conditions for which marijuana has demonstrated benefit.

Chronic Pain 50

Chronic Pain Access Patients Food 50

SpeedWeed

AUGUST 16, 2021

She also became Manager of Marijuana Law and Policy for the Drug Policy Alliance, a national non-profit set-up to draft and lead campaigns of initiatives across the U.S. As if this part of her resume isn’t impressive enough, Reiman also taught courses on substance abuse and treatment, and drug policy at U.C. and abroad. .

Chronic Pain 52

Chronic Pain Supply Chain Dispensary Medicine 52

Cannabis Law Report

JUNE 14, 2019

Agriculture Commissioner Nikki Fried announced Monday a new Medical Marijuana Advisory Committee, which she says will collaborate with the Florida Department of Agriculture and Consumer Services to help improve the state’s medical marijuana policies. Here are the details care of Sunshine State News.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

Cannabis Law Report

SEPTEMBER 28, 2019

A symposium in Limerick has heard that the medical cannabis access programme here is too restrictive and needs to be extended to include people who suffer with chronic pain. The text sanctions the total failure of repression policies, citing the now famous 2015 report of the Italian National Anti-Mafia Directorate.

Epilepsy 40

Epilepsy Chronic Pain Medicine Pharmaceutical 40

Cannabis Law Report

OCTOBER 14, 2021

Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. also known as the Canadian Association of Retired Persons) plays an active role in the creation of policy and legislation that impacts older Canadians.

Advocacy 40

Advocacy Research and Development Chronic Pain Pharmaceutical 40

Cannabis Law Report

MAY 18, 2022

chronic pain. Australian pharmaceutical-grade products are tightly regulated. Refreshingly, Australia’s policy makers were engaged in the discussion.’. During COVID-19, the company’s telemedicine and virtual health services have been in high demand. Compass also plans to expand the reach of those services. inflammation.

Medicine 52

Medicine Patients Chronic Pain Research and Development 52

The Joint Blog

DECEMBER 9, 2020

According to a new study that may come as little surprise to cannabis consumers and advocates, older individuals (those 60+) report improved quality of life and reduced pharmaceutical medications following marijuana therapy. Implications for putting medical cannabis use into everyday practice as well as policy implications are considered.

Pharmaceutical 26

Pharmaceutical Chronic Pain Marijuana Conditions 26

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development 52

Research and Development Medicine Access Media 52

Weedistry

JANUARY 30, 2019

These products are also formulated correctly and to what I would call pharmaceutical standards, which is what you want people with compromised immune systems taking into their bodies,” he said. Lobbying and marijuana policy. Thousands of new patients are expected to be added if the cannabis law ends qualifying conditions.

Recreational 40

Recreational Marijuana Legislation Patients 40

The Joint Blog

FEBRUARY 24, 2022

It is slowly gaining recognition in several countries because of the legalization policies. Further, the adoption of regulatory relaxations and favorable policies is expected to boost the product’s adoption. Furthermore, marijuana’s demand is increasing rapidly from the medical sector because of relaxation policies.

Business 26

Business Research and Development Chronic Pain Policy 26

Cannabis Law Report

JULY 15, 2019

That is yet to be done, and there is no real access without a well-informed medical and pharmaceutical community. Although this list can (and should) be periodically reviewed, Portugal lost an opportunity to expand the access to more patients and give more flexibility to the medical community on the prescription on medical cannabis.

Medicine 40

Medicine Clinical Trials Patients Access 40

SpeedWeed

JULY 29, 2021

People with Crohn’s disease, chronic pain, anxiety/depression , and asthma, just to name a few, turn to this plant medicine instead of addictive pharmaceuticals- so it’s our responsibility to provide quality flower. View Janessa Bailey’s articles. You can unsubscribe from Leafly email messages anytime.

Media 40

Media Chronic Pain Cannabis Business 40

Kind Meds (Cannabis Education Blog)

JUNE 27, 2021

At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country. Big Pharma, which includes ten of the largest powers of the pharmaceutical industry, like businesses such as Johnson & Johnson, are heavily influential when it comes to political decisions in the U.S. Nerve pain.

Pharmaceutical 99

Pharmaceutical Chronic Pain Medicine CBD 99

The Cannigma

FEBRUARY 21, 2021

Some of them are the same people who have been steering the cannabis industry since its infancy, others are massive beer and pharmaceutical companies, and some come from more unexpected places. billion by Jazz Pharmaceuticals, reportedly the largest-ever deal in the medical cannabis sector. Darrin Harris Frisby/Drug Policy Alliance).

Research and Development 143

Research and Development Pharmaceutical Recreational Cannabis 143

SpeedWeed

APRIL 9, 2021

Last year, researchers from Rice University’s Baker Institute for Public Policy undertook a new study in order to “gain insight into the needs and experiences” of the state’s medical pot users. The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts. How could we move the focus towards understanding the benefits?

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Veriheal

FEBRUARY 21, 2023

Although respondents frequently have to choose “other conditions” to meet MMJ requirements, it’s an unfortunate reality for millions due to restrictive laws and policies, further skewing data towards more universally accepted health issues.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

FEBRUARY 22, 2020

The second track for psilocybin is the pharmaceutical model. On the pharmaceutical side, the FDA’s willingness to grant breakthrough therapy status to psychedelic drugs, as mentioned above, has put psilocybin approvals in an expeditious place. At some point, federal policy finally evolves and change becomes inevitable.

Decriminalization 59

Decriminalization Research and Development Therapy Pharmaceutical 59

Cannabis Law Report

OCTOBER 20, 2019

They include, but are not limited to, the synthetic marijuana pharmaceutical companies; the Canadian marijuana industry; the alcohol industry; the pharmaceutical industry in general; the drug testing industry, and, the government. xi] “Pharmaceutical Research and Manufacturers of America (PhRMA) spent $19.7

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

The Cannigma

MARCH 12, 2021

Anxiety, that we have pharmaceuticals, doctors prescribe, and that is covered by insurance, and it’s also something that people use cannabis for, were using cannabis long before it was legal. But there’s a lot of space in between there. That is a medical condition.

Legalization 132

Legalization Patients Education Dispensary 132

Veriheal

JANUARY 5, 2023

These effects were not majorly modulated by CBD, regardless of the dosage—a discovery that the study authors say should be considered in future health policy and safety decisions. As per the results, THC (0:1) was linked to delayed verbal recall impairment and induced positive psychotic symptoms on the PANSS.

Clinical Trials 97

Clinical Trials Safety Consumption CBD 97

Weedistry

FEBRUARY 4, 2019

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. First, plenty of pharmaceutical drugs, that we broadly accept as legitimate medicine, received approval from the U.S. For comparison, about a third of pharmaceutical medicines on the U.S.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis.

Banking 45

Banking Research and Development Legislation Programs 45